Transfusion and coagulation management in major obstetric hemorrhage

Current Opinion in Anaesthesiology

Volumn 28, Issue 3, 2015, Pages 275-284

  Butwick, Alexander J ^a   Goodnough, Lawrence T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anesthesia; hemorrhage; pregnancy; transfusion

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; FIBRINOGEN; HEPARIN;

ANTIBODY TESTING; ANTICOAGULANT THERAPY; BLOOD ANALYSIS EQUIPMENT; BLOOD GROUP TYPING; BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FIBRIN CLOT; HEALTH CARE FACILITY; HOSPITAL DEPARTMENT; HOSPITAL POLICY; HUMAN; HYPOFIBRINOGENEMIA; INTERNATIONAL NORMALIZED RATIO; OBSTETRIC HEMORRHAGE; OBSTETRICS; PARTIAL THROMBOPLASTIN TIME; PATIENT CARE; PATIENT MONITORING; POINT OF CARE TESTING; POSTPARTUM HEMORRHAGE; PREGNANCY; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; THROMBOELASTOGRAPHY; THROMBOELASTOMETRY; ADULT; BLOOD; BLOOD CLOTTING; BLOOD COAGULATION DISORDERS; FEMALE; LABOR; PROCEDURES;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; FEMALE; FIBRINOGEN; HUMANS; LABOR, OBSTETRIC; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 84929991717     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000180     Document Type: Review

References (80)

1. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367:1066-1074.
2. Cantwell R, Clutton-Brock T, CooperG, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118 (Suppl 1):1-203.
3. Creanga AA, Berg C, Syverson C, et al. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol 2015; 125:5-12.
4. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009; 9:55.
5. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg 2010; 110:1368-1373.
6. Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol 2010; 202:353.e1-353.e6.
7. Lutomski JE, Byrne BM, Devane D, Greene RA. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG 2012; 119:306-314.
8. Mehrabadi A, Hutcheon JA, Lee L, et al. Epidemiological investigation of a temporal increase in atonic postpartum haemorrhage: a population-based retrospective cohort study. BJOG 2013; 120:853-862.
9. Rossen J, Okland I, Nilsen OB, Eggebo TM. Is there an increase of postpartum hemorrhage, and is severe hemorrhage associated with more frequent use of obstetric interventions? Acta Obstet Gynecol Scand 2010; 89:1248-1255.
10. Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol 2012; 120:1029-1036.
11. Jakobsson M, Gissler M, Tapper AM. Risk factors for blood transfusion at delivery in Finland. Acta Obstet Gynecol Scand 2013; 92:414-420.
12. Patterson JA, Roberts CL, Bowen JR, et al. Blood transfusion during pregnancy, birth, and the postnatal period. Obstet Gynecol 2014; 123:126-133.
13. Callaghan WM, Grobman WA, Kilpatrick SJ, et al. Facility-based identification of women with severe maternal morbidity: it is time to start. Obstet Gynecol 2014; 123:978-981.
14. D'Alton ME, Main EK, Menard MK, Levy BS. The National Partnership for Maternal Safety. Obstet Gynecol 2014; 123:973-977.
15. California Maternal Quality Care Collaborative (CMQCC). OB Hemorrhage Protocol. OB Hemorrhage Care Guidelines: Flow Chart Format V.1.4. CMQCC Hemorrhage Task Force. http://www.cmqcc.org/ob-hemorrhage. [Accessed 24 November 2014].
16. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006; 108:1039-1047.
17. Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. Green-top Guideline, No. 52. https://www.rcog.org.uk/globalassets/documents/guidelines/gt52postpartumhaem orrhage0411.pdf. [Accessed 24 November 2014].
18. Girard T, Mortl M, Schlembach D. New approaches to obstetric hemorrhage: the postpartum hemorrhage consensus algorithm. Curr Opin Anaesthesiol 2014; 27:267-274.
19. Shields LE, Smalarz K, Reffigee L, et al. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products. Am J Obstet Gynecol 2011; 205:368.e1-368.e8.
20. Mhyre JM, Shilkrut A, Kuklina EV, et al. Massive blood transfusion during hospitalization for delivery in New York State, 1998-2007. Obstet Gynecol 2013; 122:1288-1294.
21. Bateman BT, Mhyre JM, Callaghan WM, Kuklina EV. Peripartum hysterectomy in the United States: nationwide 14 year experience. Am J Obstet Gynecol 2012; 206:63.e1-8.
22. Larsen R, Titlestad K, Lillevang ST, et al. Cesarean section: is pretransfusion testing for red cell alloantibodies necessary? Acta Obstet Gynecol Scand 2005; 84:448-455.
23. Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology 2007; 106:843-863.
24. Ransom SB, Fundaro G, Dombrowski MP. Cost-effectiveness of routine blood type and screen testing for cesarean section. J Reprod Med 1999; 44:592-594.
25. Cousins LM, Teplick FB, Poeltler DM. Precesarean blood bank orders: a safe and less expensive approach. Obstet Gynecol 1996; 87:912-916.
26. Dilla AJ, Waters JH, Yazer MH. Clinical validation of risk stratification criteria for peripartum hemorrhage. Obstet Gynecol 2013; 122:120-126.
27. Goodnough LT, Daniels K, Wong AE, et al. How we treat: transfusion medicine support of obstetric services. Transfusion 2011; 51:2540-2548.
28. McClain CM, Hughes J, Andrews JC, et al. Blood ordering from the operating room: turnaround time as a quality indicator. Transfusion 2013; 53:41-48.
29. Burtelow M, Riley E, Druzin M, et al. How we treat: management of lifethreatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion 2007; 47:1564-1572.
30. Goodnough LT, Spain DA, Maggio P. Logistics of transfusion support for patients with massive hemorrhage. Curr Opin Anaesthesiol 2013; 26:208-214.
31. Pacheco LD, SaadeGR, Costantine MM, et al. The role of massive transfusion protocols in obstetrics. Am J Perinatol 2013; 30:1-4.
32. O'Keeffe T, Refaai M, Tchorz K, et al. A massive transfusion protocol to decrease blood component use and costs. Arch Surg 2008; 143:686-690.
33. Chhibber V, Greene M, Vauthrin M, et al. Is group A thawed plasma suitable as the first option for emergency release transfusion? (CME). Transfusion 2014; 54:1751-1755.
34. James AH, Paglia MJ, Gernsheimer T, et al. Blood component therapy in postpartum hemorrhage. Transfusion 2009; 49:2430-2433.
35. Johansson PI, Ostrowski SR, Secher NH. Management of major blood loss: an update. Acta Anaesthesiol Scand 2010; 54:1039-1049.
36. Kacmar RM, Mhyre JM, Scavone BM, et al. The use of postpartum hemorrhage protocols in United States academic obstetric anesthesia units. Anesth Analg 2014; 119:906-910.
37. Abdul-Kadir R, McLintock C, Ducloy AS, et al. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion 2014; 54:1756-1768.
38. Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH 2007.
39. Holmes VA, Wallace JM. Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 2005; 33:428-432.
40. Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004; 114:409-414.
41. Huissoud C, Carrabin N, Benchaib M, et al. Coagulation assessment by rotation thromboelastometry in normal pregnancy. Thromb Haemost 2009; 101:755-761.
42. Adler G, Duchinski T, Jasinska A, Piotrowska U. Fibrinogen fractions in the third trimester of pregnancy and in puerperium. Thromb Res 2000; 97:405-410.
43. Uchikova EH, Ledjev II. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 119:185-188.
44. Cerneca F, Ricci G, Simeone R, et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997; 73:31-36.
45. Oliver RD, Patterson BB, Puls JL. Thrombin clottable determination of plasma fibrinogen in pregnancy. Obstet Gynecol 1976; 47:299-303.
46. Manten GT, Franx A, Sikkema JM, et al. Fibrinogen and high molecular weight fibrinogen during and after normal pregnancy. Thromb Res 2004; 114:19-23.
47. Choi JW, Pai SH. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy. Ann Hematol 2002; 81:611-615.
48. Kobayashi T, Terao T, Maki M, Ikenoue T. Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost 2001; 27:161-167.
49. Butwick AJ. Postpartum hemorrhage and low fibrinogen levels: the past, present and future. Int J Obstet Anesth 2013; 22:87-91.
50. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5:266-273.
51. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 2012; 108:984-989.
52. de Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth 2011; 20:135-141.
53. Gayat E, Resche-Rigon M, Morel O, et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med 2011; 37:1816-1825.
54. Wikkelso AJ, Edwards HM, Afshari A, et al. Preemptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth 2015. [Epub ahead of print]
55. Mallaiah S, Barclay P, Harrod I, et al. Introduction of an algorithm for ROTEMguided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2015; 70:166-175.
56. Ahmed S, Harrity C, Johnson S, et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage: an observational study. Transfus Med 2012; 22:344-349.
57. Collins P. Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: a multicentre, prospective, double blind randomised controlled trial. ISRCTN46295339. http://www.controlled-trials.com/ISRCTN46295339/. [Accessed 24 November 2014].
58. Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc 2007; 82:864-873.
59. Haas T, Fries D, Tanaka KA, et al. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br J Anaesth 2015; 114:217-224.
60. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106:1366-1375.
61. de Lange NM, Lance MD, de Groot R, et al. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv 2012; 67:426-435.
62. Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth 2012; 109:851-863.
63. Rivard GE, Brummel-Ziedins KE, Mann KG, et al. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005; 3:2039-2043.
64. Sharma SK, Philip J, Wiley J. Thromboelastographic changes in healthy parturients and postpartum women. Anesth Analg 1997; 85:94-98.
65. Karlsson O, Sporrong T, Hillarp A, et al. Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy. Anesth Analg 2012; 115:890-898.
66. Macafee B, Campbell JP, Ashpole K, et al. Reference ranges for thromboelastography (TEG1) and traditional coagulation tests in term parturients undergoing caesarean section under spinal anaesthesia. Anaesthesia 2012; 67:741-747.
67. Karlsson O, Jeppsson A, Hellgren M. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? Int J Obstet Anesth 2014; 23:10-17.
68. Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thromboelastometry. BJOG 2009; 116:1097-1102.
69. Collins PW, Lilley G, Bruynseels D, et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood 2014; 124:1727-1736.
70. Obstetric Anaesthetists' Association and Association of Anaesthetists of Great Britain & Ireland. OAA/AAGBI guidelines for obstetric anaesthesia services. 2013 http://www.aagbi.org/sites/default/files/obstetric-anaesthetic- services-2013.pdf. [Accessed 24 November 2014].
71. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30:270-382.
72. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology 2015; 122:241-275.
73. Pasquier P, Gayat E, Rackelboom T, et al. An observational study of the fresh frozen plasma: red blood cell ratio in postpartum hemorrhage. Anesth Analg 2013; 116:155-161.
74. Kashuk JL, Moore EE, Sawyer M, et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg 2010; 251:604-614.
75. Spahn DR, Ganter MT. Towards early individual goal-directed coagulation management in trauma patients. Br J Anaesth 2010; 105: 103-105.
76. Nascimento B, Callum J, Tien H, et al. Effect of a fixed-ratio (1 : 1 : 1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ 2013; 185:E583-589.
77. Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1 : 1 : 1 vs a 1 : 1 : 2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015; 313:471-482.
78. Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 2014; 54:1389-1405.
79. Collins PW, Solomon C, Sutor K, et al. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. Br J Anaesth 2014; 113:585-595.
80. Lance MD, Ninivaggi M, Schols SE, et al. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial. Vox Sang 2012; 103:25-34.